To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids
Clinical trial NCT03273127 · COMPLETED
Trial details
- NCT number
- NCT03273127
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2017-11-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.